Effects of smoking and clinical status on lung function in human immunodeficiency virus (HIV)-seropositive subjects

Respiratory Medicine

Volumn 91, Issue 4, 1997, Pages 221-229

  Mccabe, R N ^a   Baron, J ^a   Griffin, R ^a   Omogbehin, M ^a   Snashall, P D ^a   Seed, W A ^a  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON MONOXIDE;

ADULT; AIDS RELATED COMPLEX; ARTICLE; FEMALE; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LUNG DIFFUSION CAPACITY; LUNG FUNCTION; LUNG VOLUME; LYMPHADENOPATHY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RESIDUAL VOLUME; SMOKING; TIME;

EID: 0030887763     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0954-6111(97)90042-1     Document Type: Article

References (16)

1. Suffredini A, Ognibene F, Lack E et al. Non-specific interstitial pneumonitis: A common cause of pulmonary disease in the Acquired Immunodeficiency Syndrome. Ann Intern Med 1987; 107: 7-13.
2. Backer V, Jensen BN, Pedersen C, Hertz J, Jensen TH. Acute decrease in DLCO after debut of pulmonary symptoms in HIV-infected patients. Eur Resp J 1990; 3 (Suppl. 10): 90s.
3. Kvale PA, Rosen MJ, Hopewell PC et al. A decline in the pulmonary diffusing capacity does not indicate opportunistic lung disease in asymptomatic persons infected with the human immunodeficiency virus. Am Rev Respir Dis 1993; 148: 390-395.
4. Mitchell DM, Fleming J, Pinching AJ et al. Pulmonary function in human immunodeficiency virus infection. A prospective 18-month study of serial lung function in 474 patients. Am Rev Respir Dis 1992; 146: 745-751.
5. Millar AB, Mitchell DM. Non-invasive investigation of pulmonary disease in patients positive for the human immunodeficiency virus. Thorax 1990; 45: 57-61.
6. Shaw RJ, Roussak C, Forster SM, Harris JRW, Pinching AJ, Mitchell DM. Lung function abnormalities in patients infected with the human immunodeficiency virus with and without overt pneumonitis. Thorax 1988; 43: 436-440.
7. Sankary RM, Turner J, Lipavsky AJA, Howes EL Jr, Murray JF. Alveolar-capillary block in patients with AIDS and Pneumocystis carinii pneumonia. Am Rev Respir Dis 1988; 137: 443-449.
8. Backer V, Jensen BN, Pedersen C, Hertz JB, Jensen TH. Time-related decrease in diffusion capacity in HIV-infected patients with impaired immune function. Scand J Infect Dis 1992; 24: 29-34.
9. Centers for Disease Control. Classification system for HIV infections. MMWR 1986; 35: 334-339.
10. Cotes JE, Dabbs JM, Elwood PC, Hall AM, McDonald A, Saunders MJ. Iron deficiency anaemia: Its effect on transfer factor for the lung (diffusing capacity) and ventilation and cardiac frequency during sub-maximal exercise. Clin Sci 1972; 42: 325-335.
11. Roberts CM, MacRae KD, Winning AJ, Adams L, Seed WA. Reference values and prediction equations for normal lung function in a nonsmoking white urban population. Thorax 1991; 46: 643-650.
12. Kuhlman JE, Knowles MC, Fishman EK, Siegelman SS. Premature bullous pulmonary damage in AIDS: CT diagnosis. Radiology 1989; 173: 23-26.
13. Diaz PT, Clanton TL, Pacht ER. Emphysemalike pulmonary disease associated with human immunodeficiency virus infection. Ann Intern Med 1992; 116: 124-128.
14. Buhl R, Holroyd KJ, Mastrangeli A et al. Systemic glutathione deficiency in symptom-free HIV-seropositive individuals. Lancet 1989; 1294-1297.
15. Nieman RB, Fleming J, Coker RJ, Harris JRW, Mitchell DM. Reduced carbon monoxide transfer factor (TLCO) in human immunodeficiency virus type I (HIV-I) infection as a predictor for a faster progression to AIDS. Thorax 1993; 48: 481-485.
16. Watson A, Joyce H, Hopper L, Pride NB. Influence of smoking habits on change in carbon monoxide transfer factor over 10 years in middle aged men. Thorax 1993; 48: 119-124.